Matches in SemOpenAlex for { <https://semopenalex.org/work/W2027571892> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- W2027571892 endingPage "3301" @default.
- W2027571892 startingPage "3300" @default.
- W2027571892 abstract "Background: End-stage renal disease (ESRD) in patients with type 2 diabetes mellitus (DM) is associated with a bleak prognosis. The life span of patients with DM who have undergone renal transplantation or who are undergoing dialysis is up to 30% shorter than that of individuals in the general population. Preventing or delaying the progression of renal disease from microalbuminuria to nephropathy, and ultimately, to ESRD is thus a crucial goal of DM management.Objective: This article reviews the growing worldwide problem of type 2 DM and ESRD, the renoprotective benefits of angiotensin II (AII) antagonists (AIIAs) such as losartan in patients with or without type 1 or 2 DM, potential mechanisms of renoprotection of AIIAs beyond blood pressure (BP) control, and the clinical-practice implications of available megatrials.Methods: Articles included in this review were identified using a MEDLINE search for English-language studies published between 1990 and 2003 and included the search terms diabetic nephropathy, type 2 diabetes mellitus, microalbuminuria, proteinuria, angiotensin II antagonists, angiotensin-converting enzyme inhibitors, and cardiovascular disease. Articles describing major clinical trials, new data, or new mechanisms pertinent to the management of type 2 DM were selected for review.Results: Currently, AIIAs such as losartan represent the only evidence-based treatment strategy for patients with type 2 DM and proteinuria. The Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria (IRMA-2) study, the Reduction of End Points in Non-Insulin Dependent Diabetes Mellitus with the Angiotensin II Antagonist Losartan (RENAAL) study, and the Irbesartan Type 2 Diabetic Nephropathy Trial (IDNT) indicate that AIIAs postpone the progression of type 2 diabetic renal disease at all stages, ranging from microproteinuria to overt nephropathy and ESRD, RENAAL showed that losartan improves renal outcomes in patients with type 2 DM and nephropathy over and above that attributable to BP control alone. The renoprotective effect of losartan corresponded to an average delay of 2 years in the need for dialysis or kidney transplantation.Conclusions: AIIAs such as losartan should perhaps be considered mandatory therapy in patients with diabetic nephropathy and should complement existing management strategies, such as reduced dietary protein intake, strict blood glucose control, and standard antihypertensive therapy. Collectively, these measures should improve survival and quality of life and reduce the health care burden of managing patients with diabetic nephropathy." @default.
- W2027571892 created "2016-06-24" @default.
- W2027571892 creator A5039332059 @default.
- W2027571892 creator A5073155139 @default.
- W2027571892 date "1999-12-01" @default.
- W2027571892 modified "2023-10-16" @default.
- W2027571892 title "Efficacy and safety of Losartan in renal transplant recipients" @default.
- W2027571892 cites W1997980688 @default.
- W2027571892 cites W2059844300 @default.
- W2027571892 doi "https://doi.org/10.1016/s0041-1345(99)00733-2" @default.
- W2027571892 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10616484" @default.
- W2027571892 hasPublicationYear "1999" @default.
- W2027571892 type Work @default.
- W2027571892 sameAs 2027571892 @default.
- W2027571892 citedByCount "3" @default.
- W2027571892 crossrefType "journal-article" @default.
- W2027571892 hasAuthorship W2027571892A5039332059 @default.
- W2027571892 hasAuthorship W2027571892A5073155139 @default.
- W2027571892 hasConcept C126322002 @default.
- W2027571892 hasConcept C126894567 @default.
- W2027571892 hasConcept C134018914 @default.
- W2027571892 hasConcept C2776174234 @default.
- W2027571892 hasConcept C2777180221 @default.
- W2027571892 hasConcept C2778653478 @default.
- W2027571892 hasConcept C2779561371 @default.
- W2027571892 hasConcept C2779922275 @default.
- W2027571892 hasConcept C2780091579 @default.
- W2027571892 hasConcept C2780259554 @default.
- W2027571892 hasConcept C2780288358 @default.
- W2027571892 hasConcept C2781184683 @default.
- W2027571892 hasConcept C2781203188 @default.
- W2027571892 hasConcept C2908647359 @default.
- W2027571892 hasConcept C2908929049 @default.
- W2027571892 hasConcept C555293320 @default.
- W2027571892 hasConcept C71924100 @default.
- W2027571892 hasConcept C84393581 @default.
- W2027571892 hasConcept C99454951 @default.
- W2027571892 hasConceptScore W2027571892C126322002 @default.
- W2027571892 hasConceptScore W2027571892C126894567 @default.
- W2027571892 hasConceptScore W2027571892C134018914 @default.
- W2027571892 hasConceptScore W2027571892C2776174234 @default.
- W2027571892 hasConceptScore W2027571892C2777180221 @default.
- W2027571892 hasConceptScore W2027571892C2778653478 @default.
- W2027571892 hasConceptScore W2027571892C2779561371 @default.
- W2027571892 hasConceptScore W2027571892C2779922275 @default.
- W2027571892 hasConceptScore W2027571892C2780091579 @default.
- W2027571892 hasConceptScore W2027571892C2780259554 @default.
- W2027571892 hasConceptScore W2027571892C2780288358 @default.
- W2027571892 hasConceptScore W2027571892C2781184683 @default.
- W2027571892 hasConceptScore W2027571892C2781203188 @default.
- W2027571892 hasConceptScore W2027571892C2908647359 @default.
- W2027571892 hasConceptScore W2027571892C2908929049 @default.
- W2027571892 hasConceptScore W2027571892C555293320 @default.
- W2027571892 hasConceptScore W2027571892C71924100 @default.
- W2027571892 hasConceptScore W2027571892C84393581 @default.
- W2027571892 hasConceptScore W2027571892C99454951 @default.
- W2027571892 hasIssue "8" @default.
- W2027571892 hasLocation W20275718921 @default.
- W2027571892 hasLocation W20275718922 @default.
- W2027571892 hasOpenAccess W2027571892 @default.
- W2027571892 hasPrimaryLocation W20275718921 @default.
- W2027571892 hasRelatedWork W2040299750 @default.
- W2027571892 hasRelatedWork W2049230880 @default.
- W2027571892 hasRelatedWork W2096028878 @default.
- W2027571892 hasRelatedWork W2129113925 @default.
- W2027571892 hasRelatedWork W2137999820 @default.
- W2027571892 hasRelatedWork W2142922621 @default.
- W2027571892 hasRelatedWork W2353324822 @default.
- W2027571892 hasRelatedWork W2371008856 @default.
- W2027571892 hasRelatedWork W2394243274 @default.
- W2027571892 hasRelatedWork W3120820956 @default.
- W2027571892 hasVolume "31" @default.
- W2027571892 isParatext "false" @default.
- W2027571892 isRetracted "false" @default.
- W2027571892 magId "2027571892" @default.
- W2027571892 workType "article" @default.